| CARD ID | 2355 | |
| Type of strain | Transgenic., Targeted mutant. | |
| Strain name | STOCK-Tg(Pdx1-Cre/ERT2),Slc18a2tm1c(EUCOMM) | |
| Internal Code | Pdx1-Cre ER/VMAT2-Tm1c(8) | |
| Submitter | Kume Shoen | |
| Submitter affiliation or code | - | |
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | |
| Organization code | ||
| Developer | ||
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Slc18a2 |
| Gene name | solute carrier family 18 (vesicular monoamine), member 2 |
| Allele symbol | Slc18a2tm1c(EUCOMM) |
| Allele name | solute carrier family 18 (vesicular monoamine), member 2, targeted mutation 1c, |
| MGI | MGI:106677, |
| Chromosome | 19 (54.64) , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | MicroInjection |
| OMIM |
| Gene symbol | CreER |
| Gene name | Cre recombinase ER T2 |
| Allele symbol | |
| Allele name | |
| MGI | |
| Chromosome | Unknown , |
| Gene classification | Gene to express(transgenic) |
| Method | MicroInjection |
| OMIM |
| Cre Fw | gca tta ccg gtc gat gca acg agt gat gag |
| Cre Rev | acc gtc agt acg tga gat atc tt |
| Slc18a2Ex2Fw | cga agc aaa gct atg gcc ctg agc gat ctg gtg ct |
| Slc18a2Ex3Rev | cgt gct taa tgc tgt aca ggt agc tgg gaa tga tgg g |
| Author | Gu G, Dubauskaite J, Melton DA. |
| Title | Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors |
| Journal | Development. |
| Volume | 129(10) |
| Page | 2447-57. |
| Year | 2002 |
| PMID |
| Disease name, Applicable field | Development |